Loading…

Negative printing for the reinforcement of in situ tissue engineered cartilage

In the realm of in situ cartilage engineering, the targeted delivery of both cells and hydrogel materials to the site of a defect serves to directly stimulate chondral repair. While the in situ application of stem cell-laden soft hydrogels to tissue defects holds great promise for cartilage regenera...

Full description

Saved in:
Bibliographic Details
Published in:Tissue engineering. Part A 2024-04 (ja)
Main Authors: Doyle, Stephanie, Snow, Finn, Onofrillo, Carmine, Di Bella, Claudia, O'Connell, Cathal D., Pirogova, Elena, Duchi, Serena
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the realm of in situ cartilage engineering, the targeted delivery of both cells and hydrogel materials to the site of a defect serves to directly stimulate chondral repair. While the in situ application of stem cell-laden soft hydrogels to tissue defects holds great promise for cartilage regeneration, a significant challenge lies in overcoming the inherent limitation of these soft hydrogels, which must attain mechanical properties akin to the native tissue to withstand physiological loading. We therefore developed a system where a gelatin methacryloyl hydrogel laden with human adipose derived mesenchymal stem cells is combined with a secondary structure to provide bulk mechanical reinforcement. In this study we used the negative embodied sacrificial template 3D printing technique to generate 8 different lattice-based reinforcement structures made of polycaprolactone, which ranged in porosity from 80-90% with stiffnesses from 28 ± 5 kPa to 2853 ± 236 kPa. The most promising of these designs, the hex prism edge, was combined with the cellular hydrogel and retained a stable stiffness over 41 days of chondrogenic differentiation. There was no significant difference between the hydrogel only and hydrogel scaffold group in the sulphated glycosaminoglycan production (340.46 ± 13.32 µg and 338.92 ± 47.33 µg respectively) or collagen type II gene expression. As such, the use of negative printing represents a promising solution for the integration of bulk reinforcement without losing the ability to produce new chondrogenic matrix.
ISSN:1937-3341
1937-335X
DOI:10.1089/ten.TEA.2023.0358